231 related articles for article (PubMed ID: 5282948)
1. A comparative study of the estrogenic potential of two synthetic estrogens (mestranol and ethinylestradiol).
Teter J; Stupnicki R
Acta Cytol; 1971; 15(2):167-70. PubMed ID: 5282948
[TBL] [Abstract][Full Text] [Related]
2. The effect of progestogens on vaginal cytology.
Heber KR
Acta Cytol; 1975; 19(2):103-9. PubMed ID: 47675
[TBL] [Abstract][Full Text] [Related]
3. Endometrial morphology during hormone replacement therapy with estradiol gel combined to levonorgestrel-releasing intrauterine device or natural progesterone.
Suvanto-Luukkonen E; Malinen H; Sundström H; Penttinen J; Kauppila A
Acta Obstet Gynecol Scand; 1998 Aug; 77(7):758-63. PubMed ID: 9740525
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of the estrogenicity of various synthetic estrogens by means of vaginal hormonocytology].
Teter J; Krzywdzinski K
Rev Fr Endocrinol Clin; 1971; 12(1):9-20. PubMed ID: 4944905
[No Abstract] [Full Text] [Related]
5. The use of two estrogen preparations (a combined contraceptive pill versus conjugated estrogen cream) intravaginally to treat urogenital symptoms in postmenopausal Thai women: a comparative study.
Chompootaweep S; Nunthapisud P; Trivijitsilp P; Sentrakul P; Dusitsin N
Clin Pharmacol Ther; 1998 Aug; 64(2):204-10. PubMed ID: 9728901
[TBL] [Abstract][Full Text] [Related]
6. The effect of oral contraceptives on hormonal cytology.
Kauraniemi TV; Hirvonen E
Ann Chir Gynaecol Fenn; 1974; 63(6):465-9. PubMed ID: 4441026
[TBL] [Abstract][Full Text] [Related]
7. Sensitive detection of the endocrine effects of the estrogen analogue ethinylestradiol using a modified enhanced subacute rat study protocol (OECD Test Guideline no. 407).
Andrews P; Freyberger A; Hartmann E; Eiben R; Loof I; Schmidt U; Temerowski M; Folkerts A; Stahl B; Kayser M
Arch Toxicol; 2002 May; 76(4):194-202. PubMed ID: 12029382
[TBL] [Abstract][Full Text] [Related]
8. Effect of raloxifene on the vaginal epithelium of postmenopausal women.
Delmanto A; Nahas-Neto J; Nahas EA; de Oliveira ML; Fernandes CE; Traiman P
Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):187-92. PubMed ID: 18400357
[TBL] [Abstract][Full Text] [Related]
9. [Vaginal cytological studies on the new delayed-action estrogen-ethinylestradiol sulfonate].
Hempel E; Carol W; Klinger G; Rust J; Rust G
Zentralbl Gynakol; 1975; 97(21):1281-6. PubMed ID: 1210860
[TBL] [Abstract][Full Text] [Related]
10. Vaginal cytology in patients treated with steroid combinations.
de Chiaffitelli HS; Domínguez S
Acta Cytol; 1970 May; 14(5):344-7. PubMed ID: 4104951
[No Abstract] [Full Text] [Related]
11. [Estrogens. Replacement therapy. Mestranol 80 ug (1962) versus mestranol 20 ug (1994) in postmenopausal women. Clinical, local, and metabolic effects].
Cortés Gallegos V; Sojo Aranda I
Ginecol Obstet Mex; 1995 Jan; 63():55-8. PubMed ID: 7896161
[TBL] [Abstract][Full Text] [Related]
12. [Effects of ethinyl estradiol compared with norethisterone (pure or contaminated) on vaginal keratinization of castrated rats].
Chambon Y; Huet J; Le Calve M; Picard F
C R Seances Soc Biol Fil; 1975; 169(2):391-4. PubMed ID: 126774
[TBL] [Abstract][Full Text] [Related]
13. The use of selected cytologic indices for evaluation of estrogenicity of synthetic compounds.
Teter J
Acta Cytol; 1972; 16(4):366-75. PubMed ID: 4556412
[No Abstract] [Full Text] [Related]
14. The diagnostic significance of parabasal cells. II. Rate of their disappearance and reappearance under estrogen administration and withdrawal.
Batrinos M; Eustratiades M
Acta Cytol; 1975; 19(2):100-2. PubMed ID: 1054895
[TBL] [Abstract][Full Text] [Related]
15. Randomized, multicenter, double-blind, placebo-controlled trial to evaluate the efficacy and safety of synthetic conjugated estrogens B for the treatment of vulvovaginal atrophy in healthy postmenopausal women.
Simon JA; Reape KZ; Wininger S; Hait H
Fertil Steril; 2008 Oct; 90(4):1132-8. PubMed ID: 18053998
[TBL] [Abstract][Full Text] [Related]
16. Experimental findings on the estrogenic activity of estradiol enantate.
Wiemeyer JC; Guerreiro RB; Fernandez M; Sagasta CL
Arzneimittelforschung; 1986 Nov; 36(11):1667-70. PubMed ID: 3814224
[TBL] [Abstract][Full Text] [Related]
17. Cytohormonal and morphological alterations in cervicovaginal smears of postmenopausal women on hormone replacement therapy.
Gupta S; Kumar N; Singhal N; Manektala U; Jain S; Sodhani P
Diagn Cytopathol; 2006 Oct; 34(10):676-81. PubMed ID: 16955474
[TBL] [Abstract][Full Text] [Related]
18. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
Cianci A; De Leo V
Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
[TBL] [Abstract][Full Text] [Related]
19. An open-label randomized trial to determine the most effective regimen of vaginal estrogen to reduce the prevalence of atrophic changes reported in postmenopausal cervical smears.
Bateson DJ; Weisberg E
Menopause; 2009; 16(4):765-9. PubMed ID: 19407678
[TBL] [Abstract][Full Text] [Related]
20. Vaginal cytology in endocrinopathies.
Efstratiades M; Panitsa-Faflia C; Batrinos M
Acta Cytol; 1983; 27(4):421-5. PubMed ID: 6576541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
